Monalisa Touch: A Wholesale Price Guide for Professional Sourcing

Monalisa Touch is a hyaluronic acid (HA) dermal filler manufactured by Genoss Co., Ltd. in South Korea. It is designed for professional aesthetic applications and is part of a broad category of injectables used in clinics globally. Professionals sourcing Monalisa Touch evaluate its product presentation and suitability for their established protocols.

As part of the Hyaluronic acid dermal filler catalog, Monalisa Touch stands alongside other established products. Clinics often diversify their inventory to meet various client needs and treatment areas. Products such as Elasty Plus 1CC and UNIONFILL represent other options within this professional market.

The wholesale price for Monalisa Touch is typically structured to reward bulk purchasing. Illustratively, a base price point might be around $62.0 per unit. However, this figure can decrease significantly with higher order volumes, allowing clinics to optimize their acquisition costs.

Suppliers often implement tiered discount systems. These tiers provide a clear framework for how unit prices adjust based on the quantity purchased. This approach helps clinics plan their inventory investments strategically.

These figures are illustrative and serve to demonstrate the potential savings available through volume-based purchasing agreements. Actual pricing will vary based on supplier, region, and specific contractual terms.

Strategic purchasing directly impacts a clinic's profitability. By understanding and utilizing volume discount tiers, professionals can significantly reduce their per-unit cost for Monalisa Touch. This reduction in the cost of goods sold (COGS) translates into a higher gross margin per treatment.

For example, moving from a 10-unit order to a 50-unit order could yield an 8% saving per unit in the illustrative model. This difference can accumulate substantially over time, influencing the overall financial health of an aesthetic practice. Careful inventory management and forecasting are crucial for maximizing these benefits.

Clinic owners and practitioners must establish a retail price that covers acquisition costs, overheads, practitioner fees, and desired profit margins. A common approach involves applying a markup percentage to the wholesale unit cost, then factoring in the typical amount of product used per treatment area.

For instance, if a clinic acquires Monalisa Touch at an illustrative $57.04 per unit (at the 51+ unit tier) and uses one unit per treatment, with a target retail markup of 300-400% on COGS, the retail price per treatment could range from approximately $171 to $228. This calculation must also consider local market rates, competition, and the perceived value of the service. Another comparable product in this category for professional consideration is Hyaldew.

Beyond unit price, professionals must evaluate supplier reliability, product authenticity, and logistical capabilities. Sourcing from established wholesale distributors helps ensure access to original products with verifiable supply chains. This mitigates risks associated with counterfeit products or improper handling.

Factors such as cold chain integrity, clear expiration dates, and lot number traceability are non-negotiable. An efficient sourcing strategy balances competitive pricing with the assurance of quality and compliance. Professional guides, such as insights on Verifying Genuine Re N Tox 200unit, offer principles applicable across various injectable categories.